Results 71 to 80 of about 2,017 (103)

SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT

Рациональная фармакотерапия в кардиологии, 2015
Atrial fibrillation is one of the main risk factor of ischemic stroke. Current problems of the management of patients with stroke due to non-valvular atrial fibrillation and secondary stroke prevention in these patients are considered. Data of own author’
E. A. Drozdova
doaj   +1 more source

Clinical significance of TNF-a assessment as inflammation marker in paroxysmal atrial fibrillation

RUDN Journal of Medicine, 2014
Study goal: to assess levels of TNF-α in blood serum of patients with atrial fibrillation during paroxysm and after the episode. To find possible practical application of measuring TNF-α serum levels as a diagnostic method to detect the onset of paroxysm.
E M Esedov, Z S Rustamova, S B Fitilev, I I Shkrebniova, A V Vozzhaev   +4 more
doaj  

Adherence to drug therapy in patients with atrial fibrillation

RUDN Journal of Medicine, 2010
We studied treatment adherence in 118 patients with atrial fibrillation (AF) who were between the ages of 45 and 88 years. 63.6% of patients with arrhythmia to take a medicine irregularly.
М A Kachkovskiy, O V Krasnoslobodskaya
doaj  

[Summary of the 2023 European Society of Cardiology clinical guidelines on the management of cardiovascular disease in patients with diabetes mellitus]. [PDF]

Probl Endokrinol (Mosk)
Erlikh AD, Zilov AV, Shchekochikhin DY, Shornikov SB, Bublik EV, Vinogradskaya OI, Grishkovets AI, Farmanov AG, Ryzhkova EG.   +8 more
europepmc   +1 more source

[Type 2 amiodarone-induced thyrotoxicosis: efficacy of glucocorticoid therapy, a retrospective analysis]. [PDF]

Probl Endokrinol (Mosk)
Ermolaeva AS, Fadeev VV.
europepmc   +1 more source

[Russian eligibility criteria for prescription of menopausal hormone therapy to patients with cardiovascular and metabolic diseases. Agreement document of RKO, ROAG, RAE, EAT, AFR, RNMOT, RAGG]. [PDF]

Probl Endokrinol (Mosk)
Shlyakhto EV, Dedov II, Serov VN, Sukhikh GT, Arutyunov GP, Suchkov IA, Drapkina OM, Tkacheva ON, Orlova YA, Baranov II, Andreeva EN, Yureneva SV, Yarmolinskaya MI, Smetnik AA, Villevalde SV, Koziolova NA, Sergienko IV, Yavelov IS, Irtyuga OB, Grigoryan OR, Dudinskaya EN, Zolotukhin IA, Ilyukhin ЕА.   +22 more
europepmc   +1 more source

ФИБРИЛЛЯЦИЯ ПРЕДСЕРДИЙ КАК ПРЕДИКТОР ЭФФЕКТИВНОСТИ РЕНАЛЬНОЙ ДЕНЕРВАЦИИ В ЛЕЧЕНИИ ПАЦИЕНТОВ С РЕФРАКТЕРНОЙ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ

Евразийский Кардиологический Журнал, 2017

doaj  

Some of the next articles are maybe not open access.

Related searches:

О чем «молчит» фибрилляция предсердий: методы, частота и клинические последствия ее выявления у бессимптомных пациентов

Kreativnaya kardiologiya, 2021
С. Ю. Сергуладзе, Инга В. Тетвадзе, И. В. Проничева   +2 more
semanticscholar   +1 more source

Эпикардиальное ожирение и фибрилляция предсердий: акцент на предсердном жировом депо

, 2020
Евгений Станиславович Мазур, В.В. Мазур, Николай Дмитриевич Баженов, Сергей Васильевич Колбасников, Оксана Владимировна Нилова   +4 more
semanticscholar   +1 more source

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly